Skip to main content
. 2021 Sep 27;11:646584. doi: 10.3389/fonc.2021.646584

Table 9.

Comparison of organs at risk (priority level I and II) in T3-4 NPC patients.

Median (IQR) P-value
OAR Objective IMRT VMAT TOMO P I vs. V I vs. T V vs. T
Brain stem Dmax (Gy) 54.26 (51.68-56.47) 55.50 (51.27-58.72) 52.50 (48.36-55.46) 0.005 0.495 0.192 0.004
Brain stem_PRV D0.03cc (Gy) 56.99 (54.26-63.71) 62.13 (54.95-64.87) 60.21 (55.83-64.81) 0.867 _ _ _
Optic chiasm Dmax (Gy) 44.79 (37.66-48.40) 41.65 (31.82-49.91) 45.82 (34.86-48.35) 0.717 _ _ _
Optic chiasma_PRV D0.03cc (Gy) 53.12 (45.23-55.99) 50.96 (47.05-57.14) 54.13 (46.59-56.64) 0.538 _ _ _
Optic nerves_L Dmax (Gy) 38.28 (27.50-45.20) 37.43 (27.82-45.55) 42.61 (37.29-44.40) 0.06 _ _ _
Optic nerves_L PRV D0.03cc (Gy) 46.24 (33.09-52.49) 45.42 (35.24-56.66) 51.90 (46.09-54.34) 0.005 1 0.041 0.006
Optic nerves_R Dmax (Gy) 40.45 (25.32-50.77) 39.24 (27.17-49.94) 43.89 (35.92-50.30) 0.156 _ _ _
Optic nerves_R PRV D0.03cc (Gy) 47.91 (35.70-57.67) 49.90 (39.98-56.14) 53.11 (45.32-54.95) 0.129 _ _ _
Spinal cord Dmax (Gy) 39.34 (38.42-40.50) 41.84 (39.15-43.69) 37.00 (32.38-40.78) 0.001 0.092 0.269 <0.001
Spinal cord_PRV D0.03cc (Gy) 45.38 (41.93-49.18) 46.66 (43.71-51.37) 44.76 (41.06-52.05) 0.467 _ _ _
Temporal lobe_L Dmax (Gy) 77.01 (76.41-78.28) 78.06 (75.01-80.22) 75.54 (73.77-76.74) 0.002 1 0.016 0.004
Temporal lobe_L PRV D0.03cc (Gy) 76.95 (76.26-77.96) 78.27 (75.73-80.28) 75.73 (74.91-77.05) 0.003 0.84 0.076 0.003
Temporal lobe_R Dmax (Gy) 77.46 (77.06-79.48) 77.75 (75.42-80.80) 75.40 (74.56-77.26) 0.001 1 0.004 0.004
Temporal lobe_R PRV D0.03cc (Gy) 77.55 (77.02-78.91) 79.02 (75.82-80.54) 75.48 (74.58-77.19) 0.013 1 0.033 0.033

IMRT/I, intensity modulated radiation therapy; VMAT/V, volumetric modulated arc therapy; TOMO/T, tomotherapy; OAR, organ at risk; IQR, inter-quartile range; Gy, gray; PRV, planning risk volume; L, left; R, right; Dmax, the maximum dose; D0.03cc, an approximate maximum dose for the organs at risk.